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UNIT 2.2Protection of 2′-Hydroxy Functions of
Ribonucleosides
The methods used to protect 2′-hydroxy
functions of ribonucleosides have recently
been reviewed (Beaucage and Iyer, 1992; Son-
veaux, 1994; Beaucage and Caruthers, 1996).
In addition, there have been earlier brief re-
views (Ohtsuka and Iwai, 1987; Reese, 1989).
The main purpose of this article is to discuss
2′-protection in the context of effective oligori-
bonucleotide synthesis. For this reason, empha-
sis will be placed on what are now, or are likely
to become, the 2′-protecting groups of choice
in the synthesis of oligo- and poly-ribonu-
cleotides (RNA sequences). As a result, only
some of the protecting groups that have been
suggested for this purpose are considered in
detail here, and some interesting chemistry has
necessarily been omitted.
CONSIDERATIONS FOR
2′-PROTECTING GROUPS IN
OLIGORIBONUCLEOTIDE
SYNTHESIS
There are three main general criteria that all
protecting groups should fulfill (Reese, 1978).
(1) They should be easy to introduce and, as
part of this criterion, the reagents involved in
their introduction should be readily accessible.
(2) They should be stable and remain intact
until it is appropriate to remove them. (3) They
should be removable at the appropriate time
using conditions under which the desired prod-
uct is completely stable. In the case of chiral
substrates such as ribonucleosides, achiral pro-
tecting groups are desirable for analytical (e.g.,
NMR, TLC, and HPLC) purposes. In the case
of all substrates, it is desirable that the intro-
duction of protecting groups should not result
in unduly complex NMR spectra.
The successful chemical synthesis of
polynucleotides (including RNA sequences)
depends on the choice of suitable protecting
groups and effective phosphorylation proce-
dures. Arguably the most crucial single deci-
sion that has to be made in oligoribonucleotide
synthesis is the choice of the protecting group
(R; see S.1) for the 2′-hydroxy functions
(Reese, 1978). This protecting group must re-
main intact until the very last step of the syn-
thesis (Fig. 2.2.1), and must then be removable
under conditions that are mild enough to avoid
subsequent attack of the released 2′-hydroxy
functions (see S.2) on the vicinal phosphodi-
ester internucleotide linkages, thereby leading
to their cleavage or migration.
Protecting groups are often removed hydro-
lytically under either basic or acidic conditions.
Cleavage of interribonucleotide linkages can
occur under relatively mild basic conditions
(Järvinen et al., 1991; Kuusela and Lönnberg,
1994). This process, illustrated in Figure
2.2.2A, essentially involves an ester exchange
reaction between the 2′-hydroxy function of the
3′-linked nucleoside residue and the 5′-hy-
droxy function of the 5′-linked nucleoside resi-
due, leading to a (2′,3′)-cyclic phosphate (S.3).
This intermediate then undergoes further base-
catalyzed hydrolysis to give a mixture of iso-
meric 2′- and 3′-phosphates (S.5 and S.6, re-
spectively). Under acidic conditions (Fig.
2.2.2B), internucleotide cleavage and migra-
tion can both occur (Griffin et al., 1968). These
processes are both believed to proceed via a
phosphorane intermediate (S.7; Järvinen et al.,
1991). If the P-O(2′) bond is then cleaved,
starting material S.2 is regenerated. If the P-
O(3′) bond is cleaved, the isomeric product S.8
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Figure 2.2.1 Scheme showing protected 2′-hydroxy functions. B and B′ are bases.
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with the migrated internucleotide linkage is
obtained. Finally, if the P-O(5′) bond is cleaved,
the (2′,3′)-cyclic phosphate S.3 is obtained. The
cyclic phosphate S.3 undergoes further hy-
drolysis to give an isomeric mixture of the
corresponding 2′- and 3′-phosphates (S.5 and
S.6, respectively) under acidic as well as under
basic conditions.
The significance of these reactions in the
context of oligo- and poly-ribonucleotide syn-
thesis will be considered later. However, it is
clearly of crucial importance that the 2′-protect-
ing group should strictly satisfy the above cri-
teria (1) and (2). As will become apparent, this
is a very demanding requirement, as the 2′-pro-
tecting group must also be fully compatible
with the groups that are used to protect the
5′-terminal hydroxy function, the base resi-
dues, and the internucleotide linkages. It is
therefore appropriate to consider these other
protecting group requirements at the outset.
Protection of the 5′-Terminal Hydroxy
Function
Figure 2.2.3 illustrates a number of groups
(R′ in S.9) used to protect the 5′-terminal hy-
droxy function. Although a good deal of work
has been carried out on the synthesis of oligori-
bonucleotides in solution, most of the recent
studies in this area have been concerned with
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Figure 2.2.2 Scheme showing cleavage of interribonucleotide linkages under (A) basic and (B)
acidic conditions. Although only shown in panel A, the hydrolysis of S.3 can yield either the
2′-phosphate (S.5) or the 3′-phosphate (S.6) under either basic or acidic conditions.
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solid-phase synthesis. The 5′-terminal protect-
ing group (R′) that has been used most widely
for this purpose is the (di-p-anisyl)phenyl-
methyl  group (also known as 4,4′-di-
methoxytrityl or DMTr; S.10b; Schaller et al.,
1963; UNIT 2.3). The 9-phenylxanthen-9-yl
(pixyl or Px, S.11) group has very similar prop-
erties to the DMTr group and is equally suitable
(Chattopadhyaya and Reese, 1978).
The somewhat less labile p-ani-
syl(diphenyl)methyl group (4-mono-
methoxytrityl or MMTr; S.10a; Schaller et al.,
1963) has also been used, but its greater stabil-
ity to acid makes it generally less suitable. The
great advantage of the DMTr (S.10b) and Px
(S.11) protecting groups in solid-phase synthe-
sis, and perhaps also in solution-phase synthe-
sis, is that they can be rapidly and quantitatively
removed by treatment with acids, such as di-
and tri-chloroacetic acids, in anhydrous dichlo-
romethane solution (Sproat and Gait, 1984). A
further advantage shared by all three of these
protecting groups is that with acid treatment
they give rise to colored carbocations that can
easily be assayed spectrophotometrically. This
permits coupling efficiencies to be monitored.
Clearly, if one of these three protecting groups
is used in oligoribonucleotide synthesis, the
2′-protecting group (R in formula S.9) must be
completely stable under the acidic conditions
required for 5′-deprotection.
Numerous other 5′-protecting groups have
been suggested (Sonveaux, 1994; UNIT 2.3), some
of which are removable under mildly basic or
virtually neutral conditions. Protecting groups
in this latter category include 9-fluorenyl-
methoxycarbonyl (Fmoc; S.12; Pathak and
Chattopadhyaya, 1985), levulinyl (Lev; S.13;
van Boom and Burgers, 1976), 2-(dibro-
momethyl)benzoyl (Dbmb; S.14; Chattopad-
hyaya et al., 1979), and 2-(isopropyl-
thiomethoxymethyl)benzoyl (Ptmt; S.15;
Brown et al., 1989a). None of these protecting
groups has found widespread use in the solid-
phase synthesis of RNA sequences, but some
have proved to be useful in solution-phase syn-
thesis.
Protection of Base Residues
The protection of base residues is illustrated
in Figure 2.2.4. In the solid-phase synthesis of
RNA sequences (Rao et al., 1993), adenine,
cytosine, and guanine residues are generally
protected by N-acylation (as in S.16, S.18, and
S.19, respectively), while uracil residues are
left unprotected (as in S.23; UNIT 2.1). The N-acyl
protecting groups are usually removed by am-
monolysis in the step before the removal of the
2′-protecting groups. As RNA can undergo in-
ternucleotide cleavage (Fig. 2.2.2A) under am-
monolytic conditions, the base-protecting
groups must be removable using conditions
under which the 2′-protecting groups are com-
pletely stable. Thus, the choice of an N-acyl
protecting group for a particular base residue
is, to some extent, dependent on the 2′-protect-
ing group used.
The dimethylaminomethylene protecting
group, which is also removable under am-
monolytic conditions, has been recommended
for the protection of adenine and guanine resi-
dues (as in S.17 and S.20, respectively; Vinayak
et al., 1992). Particularly in the solution-phase
synthesis of RNA sequences, it may be desir-
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Figure 2.2.3 Several protecting groups for 5′-terminal hydroxy functions.
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able to protect guanine residues on O6 as well
as on N2 (as in S.21 and S.22). Aryl protecting
groups are particularly suitable for this purpose
(as in S.21; Ar = 2-nitrophenyl, 3-chlorophenyl,
and 3,5-dichlorophenyl; Jones et al., 1981;
Reese and Skone, 1984; Brown et al., 1989a);
they may readily be removed by treatment with
the N1,N1,N3,N3-tetramethylguanidinium salt
of (E)-2-nitrobenzaldoxime S.26 or of (E)-
pyridine-2-carboxaldoxime S.27 (oximate
treatment; Reese and Zard, 1981) before the
ammonolytic removal of the N-acyl protecting
groups. The N,N-diphenylcarbamoyl group (as
in S.22; Kamimura et al., 1984) is removable
by ammonolysis (UNIT 2.1).
In the solution-phase synthesis of RNA se-
quences, it may also be desirable to protect
uracil residues on O4 with an aryl group (as in
S.24; Ar = 2,4-dimethylphenyl; Jones et al.,
1981) or on N3 with an acyl group (as in S.25;
R = 4-MeO.C6H4; Kamimura et al., 1984).
O4-Aryl and N3-acyl protecting groups may be
removed from uracil residues by oximate treat-
ment and by ammonolysis, respectively (UNIT
2.1). It should be noted that the ammonolytic
and oxime treatment conditions are both basic.
Protection of Internucleotide Linkages
Virtually all of the groups commonly used
to protect the internucleotide linkages in both
solid- and solution-phase oligo- and poly-ri-
bonucleotide synthesis are removed under ba-
sic conditions (Fig. 2.2.5). The 2-cyanoethyl
group (as in S.28; Sinha et al., 1983) is by far
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Figure 2.2.4 Several protecting groups for base residues (A: S.16 and S.17; C: S.18; G: S.19 to
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Figure 2.2.5 Several protecting groups for internucleotide linkages. Ar is phenyl or another aryl
group.
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the most commonly used protecting group for
the internucleotide linkages in the solid-phase
synthesis of RNA sequences, and the 2-chlor-
ophenyl group (as in S.29; Reese, 1970) has
been widely used for this purpose in solution-
phase synthesis. Another approach to the syn-
thesis of oligoribonucleotides was pioneered
by Hata and co-workers (Honda et al., 1984)
and involves intermediate S-aryl phos-
phorothioates (S.30, Ar = Ph). 2-Cyanoethyl
protecting groups are usually removed at the
same time as N-acyl base-protecting groups by
treatment with ammonia (Sinha et al., 1983).
2-Chlorophenyl-protected oligo- and poly-ri-
bonucleotides are best unblocked by treatment
with the conjugate base of (E)-2-nitrobenzal-
doxime S.26 or (E)-pyridine-2-carboxal-
doxime S.27 (Reese et al., 1978; Reese and
Zard, 1981). S-Aryl phosphorothioates (S.30),
which are masked phosphodiesters, may also
be unblocked by oximate treatment (Kamimura
et al., 1984). In order to avoid internucleotide
cleavage (Fig. 2.2.2A), it is necessary that the
2′-protecting group (R in S.28, S.29, and S.30)
should be completely stable under the basic
conditions used in the unblocking of the inter-
nucleotide linkages.
PROTECTION OF THE
2′-HYDROXY FUNCTION IN
OLIGORIBONUCLEOTIDE
SYNTHESIS
It is clear from the above discussion that the
requirements for a 2′-protecting group in oligo-
and polyribonucleotide synthesis are very de-
manding indeed. With regard to solid-phase
synthesis, in addition to meeting the above
general criteria for protecting groups, it is cru-
cially important that 2′-protecting groups be
stable to repeated exposure to the acidic condi-
tions required to remove the 5′-terminal DMTr
protecting group S.10b.  The 2′-protecting
groups must also be stable under the basic
conditions (i.e., concentrated aqueous ammo-
nia and oximate ions) required to unblock the
base residues and the internucleotide linkages.
It is further desirable that 2′-protecting groups
not be excessively bulky and thereby impede
the coupling process. For the successful removal
of the 2′-protecting groups, it must always be
borne in mind that RNA is a very sensitive
material that is unstable under both acidic and
basic conditions and in the presence of various
hydrolytic enzymes. It is therefore desirable
that manipulation should be kept to a minimum
in the isolation of fully unblocked RNA.
Ether Protecting Groups
The protection of the 2′-hydroxy functions
as readily cleavable ether groups would appear
at first sight to be an attractive proposition.
Indeed, the possibility of using the benzyl pro-
tecting group was first examined over 30 years
ago (Griffin et al., 1966). Uridine was converted
into its 2′-O-benzyl derivative S.31, which was
then successfully converted via the protected
dinucleoside phosphate S.32 into uridylyl-
(3′→5′)-uridine (S.33; Fig. 2.2.6). The benzyl
protecting group, which is stable both to acid-
and base-catalyzed hydrolysis, was removed by
catalytic hydrogenolysis in the presence of pal-
ladized charcoal. However, it was subsequently
reported that concomitant hydrogenation of the
uracil 5,6-double bond can occur (Reitz and
Pfleiderer, 1975). There is also a danger that
the total removal of all of the 2′-protecting
groups of per-2′-O-benzylated RNA sequences
may not always be possible.
The 2-nitrobenzyl group (as in S.34; Fig.
2.2.7), which was introduced by Ikehara and
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Figure 2.2.6 Scheme showing the preparation of uridylyl-(3′→5′)-uridine from 2′-O -benzyl (Bn)-
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Current Protocols in Nucleic Acid Chemistry
2.2.5
Protection of
Nucleosides for
Oligonucleotide
Synthesis 
co-workers (Ohtsuka et al., 1978), is potentially
a more useful 2′-protecting group. Like the
benzyl group, it is stable both to acid- and
base-catalyzed hydrolysis. However, it may be
cleaved photochemically by irradiation with
ultraviolet light (λ > 280 nm). It was later
reported that photolytic cleavage of the 2-ni-
trobenzyl protecting group proceeds more effi-
ciently in slightly acidic (pH 3.5) 0.1 mol dm−3
ammonium formate solution (Hayes et al.,
1985). A serious drawback to the use of the
2-nitrobenzyl protecting group is that the pho-
tolytic cleavage reaction does not always pro-
ceed quantitatively (Ohtsuka and Iwai, 1987),
especially in the unblocking of relatively high-
molecular-weight RNA sequences.
Takaku and co-workers have used the 4-
methoxybenzyl (as in S.35a; Takaku and
Kamaike, 1982; Takaku et al., 1984) and 3,4-
dimethoxybenzyl (S.35b; Takaku et al., 1986)
groups to protect 2′-hydroxy functions in solu-
tion-phase oligoribonucleotide synthesis. The
4-methoxybenzyl protecting groups were re-
moved from a hexaribonucleoside pentaphos-
phate (Takaku et al., 1984) by treatment for 3
hr at room temperature with a reagent prepared
by adding triphenylmethyl tetrafluoroborate
(∼0.10 mmol/mL) to acetonitrile/water (4:1
v/v). However, Takaku et al. (1986) reported
that incomplete unblocking and some cleavage
of the glycosidic linkages can occur under these
presumably rather acidic conditions. Some
cleavage and migration of the internucleotide
linkages might also be expected to occur. The
3,4-dimethoxybenzyl protecting group may be
removed (Takaku et al., 1986) under somewhat
milder conditions by treatment with 2,3-di-
chloro-5,6-dicyano-1,4-benzoquinone (DDQ)
in wet dichloromethane; this group would ap-
pear to be potentially more promising than the
4-methoxybenzyl group for the protection of
the 2′-hydroxy functions in oligoribonu-
cleotide synthesis.
The tert-Butyldimethylsilyl Protecting
Group
The tert-butyldimethylsilyl group (TBDMS;
as in S.37 and S.38; Fig. 2.2.8) was originally
suggested by Stork and Hudrlik (1968) for the
protection of enols, and was first used by Corey
and Venkateswarlu (1972) for the protection of
alcoholic hydroxy functions. Ogilvie and co-
workers (Ogilvie et al., 1974) then introduced
it as a protecting group for the 2′-hydroxy
functions of ribonucleoside building blocks.
The TBDMS group is at present the most
widely used 2′-protecting group in solid-phase
oligoribonucleotide synthesis (Damha and
Ogilvie, 1993). It meets some but by no means
all of the above general requirements for pro-
tecting groups. It may be readily introduced
(Usman et al., 1987), for example, by treating
a 5′-O-DMTr-ribonucleoside derivative (S.36)
with tert-butylchlorodimethylsilane and imida-
zole in N,N-dimethylformamide (DMF) solu-
tion (Fig.2.2.8).
Although the regiochemistry of the silyla-
tion reaction can be controlled to some extent
(Hakimelahi et al., 1982), a mixture of 2′- and
3′-isomers (S.37 and S.38, respectively) is in-
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Figure 2.2.7 The 2-nitrobenzyl (S.34), 4-methoxybenzyl (S.35a), and 3,4-dimethoxybenzyl
(S.35b) protecting groups.
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variably obtained. Fortunately, such isomeric
mixtures can usually be separated by chroma-
tography on silica gel. However, great care has
to be taken in the purification and isolation of
the 2′-protected ribonucleoside building blocks
(S.37), as the TBDMS group readily migrates
from the 2′- to the 3′-hydroxy function and vice
versa.
Interconversion between the adenosine de-
rivatives S.39 and S.40 (Fig. 2.2.9) was found
to be a base-catalyzed first-order equilibration
reaction (Jones and Reese, 1979). Equilibration
rates were observed to be the same in both
directions, and the equilibrium constant was
estimated to be 1.0. The half time (t1/2) for
equilibration in anhydrous pyridine solution at
36°C was 19 hr. The equilibration rate was
increased by a factor of 3.0 when 0.1 mol equiv.
(with respect to substrate) of benzylamine (pKa
9.34) was added. Equilibration was faster still
(t1/2 = ∼1 hr at 36°C) in methanol-d4 solution
without added base. When 0.1 mol equiv. of
triethylamine (pKa 10.87) was added to the
methanol-d4 solution at 20°C, equilibration
was complete within ∼5 min.
Precautions must be taken to avoid migra-
tion of the TBDMS protecting group during the
purification and isolation of 2′-O-TBDMS-5′-
O-DMTr-ribonucleoside derivatives (S.37) and
during the course of their conversion into the
required monomeric building blocks. Other-
wise, the resulting synthetic RNA sequences
will be contaminated with material containing
(2′→5′)-internucleotide linkages. Thus, in the
preparation of 3′-phosphoramidite building
blocks (S.41; Fig. 2.2.10), it is advisable that
the presence of a strong base such as diiso-
propylethylamine be avoided. Usman and co-
workers (Scaringe et al., 1990) have recom-
mended that a mixture of 2,4,6-collidine and
1-methylimidazole be used. Although the pres-
ence of contaminating isomeric 2′-phos-
phoramidites (S.42) can be detected above a
certain level by 31P NMR spectroscopy, these
impurities cannot readily be removed.
It was recently reported that the oligoribonu-
cleotide r[(Up)20U], prepared by treating its
per-2′-O-TBDMS derivative with tetra-n-butyl-
ammonium fluoride, contained an average of
1.3% (2′→5′)-internucleotide linkages (Mor-
gan et. al., 1995). As acid was not used either
during or after the unblocking process, a rea-
sonable explanation for this observation is that
the phosphoramidite S.41 (B = uracil-1-yl)
used in its synthesis was contaminated with
1.3% of its 2′-isomer (S.42; B = uracil-1-yl).
Using an analytical procedure similar to that
described by Morgan et al., it was later con-
cluded that some commercially supplied 2′-O-
TBDMS-protected ribonucleoside phos-
phoramidites (S.41) were contaminated with
comparable amounts (i.e., >1%) of isomeric
2′-phosphoramidites (S.42; Reese et al., unpub.
observ.). However, some other batches of com-
mercially supplied material were estimated to
contain smaller quantities of the corresponding
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Figure 2.2.9 Scheme showing the interconversion of the 2′-O - (S.39) and 3′-O - (S.40) TBDMS
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2′-isomer (S.42; Reese et al., unpub. observ.).
It would therefore appear that migration of the
TBDMS group can to a large extent be control-
led if careful manufacturing protocols are ob-
served.
The use of the TBDMS protecting group in
the solid-phase synthesis of RNA sequences
can lead to long coupling times and unsatisfac-
tory coupling efficiencies, possibly due to the
bulk of this protecting group. However, the use
of 5-ethylthio-1H-tetrazole (S.43b;  Fig.
2.2.11) instead of 1H-tetrazole (S.43a) as the
phosphoramidite activator can result in shorter
coupling times and higher quality products
(Sproat et al., 1995; UNIT 3.5). One important
advantage of the TBDMS protecting group is
that it appears to be stable under the acidic
conditions used to remove the 5′-terminal
DMTr protecting group in solid-phase synthe-
sis.
Problems have arisen in the unblocking of
2′-O-TBDMS-protected RNA sequences. The
standard unblocking procedure used in the
solid-phase synthesis of DNA sequences in-
volves heating the fully loaded solid support
with concentrated aqueous ammonia at 55°C
overnight (Brown and Brown, 1991). These
ammonolytic conditions lead to the release of
the oligodeoxyribonucleotides from the solid
support, the removal of the 2-cyanoethyl pro-
tecting groups from the internucleotide link-
ages, and the removal of N-acyl protecting
groups from the base residues (in oligodeoxyri-
bonucleotide synthesis, the adenine and cyto-
sine residues are usually protected with benzoyl
groups as in S.16 and S.18, R = Ph, and the
guanine residues are usually protected with
isobutyryl groups as in S.19, R = Me2CH). If
these ammonolysis conditions are also used in
the unblocking of 2′-O-TBDMS-protected oli-
goribonucleotides, appreciable loss of the 2′-
O-TBDMS protecting groups and concomitant
cleavage of the internucleotide linkages are
likely to occur (Stawinski et al., 1988). This
problem of premature removal of 2′-O-
TBDMS protecting groups has been largely
overcome by protecting the base residues with
more labile acyl groups (Chaix et al., 1989),
and by replacing concentrated aqueous ammo-
nia with a more selective reagent such as 35%
aqueous ammonia/ethanol (3:1 v/v) ammo-
nia/ethanol (Mullah and Andrus, 1996), anhy-
drous ethanolic ammonia (Goodwin et al.,
1994), or aqueous methylamine (Wincott et al.,
1995). Téoule and co-workers (Chaix et al.,
1989) have recommended that adenine and
guanine residues be protected with phe-
noxyacetyl groups (as in S.16 and S.19, R =
CH2OPh) and that cytosine residues be acety-
lated (as in S.18, R = Me). These workers found
that the half times for removal of the latter
protecting groups in aqueous ammonia/ethanol
(1:1 v/v) at room temperature ranged from 10
to 15 min. It should therefore be possible com-
pletely to unblock base residues that are pro-
tected in this way without any significant loss
of the 2′-O-TBDMS protecting groups and
without internucleotide cleavage.
In the final unblocking step, the TBDMS
protecting groups are removed from the 2′-hy-
droxy functions of the synthetic RNA se-
quences. Until recently, a solution of tetra-n-
butylammonium fluoride in tetrahydrofuran
(Damha and Ogilvie, 1993) was almost always
used for this unblocking process. However, it
has been reported that the use of the latter
reagent results in an inconvenient work-up pro-
cedure and can lead to incomplete unblocking
(Sproat et al., 1995). More recently, it has been
suggested that triethylamine trihydrofluoride
(S.44; Fig. 2.2.11; Gasparutto et al., 1992;
Westman and Strömberg, 1994) is a more suit-
able reagent for this purpose. Both the neat
reagent S.44, which is slightly acidic as evi-
denced by the concomitant loss of 5′-O-DMTr
protecting groups (Mullah and Andrus, 1996),
and a solution of S.44 and triethylamine in
1-methylpyrrolidone (Wincott et al., 1995)
have been used.
There now seems to be little doubt that, if
the above precautions are taken and the most
suitable base-protecting groups and reagents
are used, the TBDMS group may be used ef-
fectively for the protection of the 2′-hydroxy
functions in the solid-phase synthesis of RNA
sequences. 2′-O-TBDMS-ribonucleoside 3′-
H-phosphonate building blocks (S.45; Fig.
2.2.12) have also been used successfully in the
solid-phase synthesis of oligoribonucleotides
(Rozners et al., 1994). It is reasonable to assume
that the same precautions and considerations
that apply to solid-phase synthesis based on
phosphoramidite building blocks (S.41) should
N
N
H
N
N
R
43a, R = H
43b, R = SEt
Et3N • 3HF
44
Figure 2.2.11 Phosphoramidite activators 5-
ethylthio-1H-tetrazole (S.43b) and 1H-tetrazole
(S.43a), and the unblocking reagent triethyl-
amine trihydrofluoride (S.44).
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be taken into account if good quality RNA
sequences are to be obtained from the corre-
sponding H-phosphonates (S.45).
Acetal Protecting Groups
In general, acetal groups have several dis-
tinct advantages over the TBDMS group as far
as the protection of the 2′-hydroxy functions in
oligoribonucleotide synthesis is concerned.
First, acetal protecting groups can usually be
placed regiospecifically on the 2′-hydroxy
functions (see below) and, once in position,
they cannot migrate. Secondly, they are com-
pletely stable under the basic conditions that
normally obtain during the unblocking of inter-
nucleotide linkages and base residues. Thirdly,
the 2′-protected RNA sequences obtained after
the removal of the other protecting groups (Rao
et al., 1993) can be purified under neutral or
basic conditions without any danger of endonu-
clease-promoted digestion. However, there is
one important drawback to the use of acetal
protecting groups in that they are generally
removed by acid-catalyzed hydrolysis. Unless
the acidic conditions used are particularly mild,
both cleavage and migration of the internu-
cleotide linkages can occur (Griffin et al., 1968;
Capaldi and Reese, 1994; Fig. 2.2.2B). While
cleavage of internucleotide linkages is clearly
highly undesirable, migration is a very much
more serious matter as it is virtually impossible
to free even a relatively low-molecular-weight
RNA sequence from contaminating isomeric
sequences containing one or more (2′→5′)-in-
ternucleotide linkages.
The tetrahydropyran-2-yl (Thp) group
In the 1960s, the use of the 2′-O-tetrahy-
dropyran-2-yl protecting group (Thp) in oli-
goribonucleotide synthesis was examined
(Smith et al., 1962; Smrt and Šorm, 1962;
Griffin and Reese, 1964). Pure 2′-O-Thp de-
rivatives of uridine and adenosine (S.47a and
S.47b, respectively) were prepared according
to the procedure indicated in Figure 2.2.13, and
were converted into dinucleoside phosphates
by the methods then available (Griffin and
Reese, 1964; Griffin et al., 1968). Careful un-
blocking studies were carried out in 0.01 mol
dm−3 hydrochloric acid (pH 2.0) at 24°C (Grif-
fin et al., 1968), and the half time (t1/2) for the
conversion of 2′-O-Thp-UpU (S.49; Fig.
2.2.14) into completely unprotected uridylyl-
(3′→5′)-uridine (UpU; S.50) was found to be
29 min. It can therefore be estimated that
>99.9% removal of the Thp group would occur
in <5 hr under these conditions.
It was also found that after UpU (S.50) had
been allowed to stand in 0.01 mol dm−3 hydro-
chloric acid (pH 2.0) at 25°C for 216 hr, it
underwent ∼99% ribonuclease A–catalyzed di-
gestion to uridine-3′-phosphate and uridine,
thereby indicating that not more than 1%
isomerization to uridylyl-(2′→5′)-uridine
(S.51) had occurred (Griffin et al., 1968). Under
these conditions (i.e., pH 2.0, 25°C, 216 hr),
UpU also underwent ∼0.5% hydrolytic cleav-
age (Fig. 2.2.2B). It can therefore be estimated
that in the time required for >99.9% removal
of the Thp protecting group from 2′-O-Thp-
UpU, not more than 0.02% phosphoryl migra-
tion and 0.01% internucleotide cleavage would
be expected to occur. Thus, it seemed reason-
able to conclude from the data then available
that the Thp group was suitable for the protec-
tion of the 2′-hydroxy functions in oligoribonu-
cleotide synthesis.
O
O
BDMTrO
OTBDMS
45
P O
H
O
Figure 2.2.12 2′-O -TBDMS-ribonucleoside
3′-H-phosphonate.
O
AcO
BAcO
OH
46
i, ii O
HO
BHO
O
47
O
(Thp)
O
48
a, B = uracil-1-yl
b, B = adenin-9-yl
Figure 2.2.13 Scheme showing preparation of 2′-O -Thp derivatives of uridine and adenosine.
Reagents: (i) 3,4-dihydro-2H-pyran (S.48), toluene-4-sulfonic acid (TsOH), dioxane; (ii) NaOMe,
MeOH.
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A particular disadvantage of the Thp group
is that it is chiral, and therefore its use in the
protection of ribonucleoside derivatives and
other chiral compounds leads to mixtures of
diastereoisomers. Thus, two diastereoisomers
each of 2′-O-Thp-uridine (S.47a) and 2′-O-
Thp-adenosine (S.47b) were obtained (Fig.
2.2.13; Griffin et al., 1968). Although both pairs
of diastereoisomers were easily separable and
all four compounds were obtained as pure crys-
talline solids, this is clearly an undesirable
complication.
The 4-methoxytetrahydropyran-4-yl (Mthp)
group
A search for an achiral alternative to the Thp
protecting group led to the introduction of the
4-methoxytetrahydropyran-4-yl group (Mthp;
Reese et al., 1967; 1970). 2′-O-Mthp deriva-
tives of ribonucleosides (S.54) were first pre-
pared from 3′,5′-di-O-acyl-ribonucleosides
(S.53; Fig. 2.2.15). However, they are more
conveniently prepared from the corresponding
3′,5′-O-(1,1,3,3-tetraisopropyl- disiloxan-1,3-
diyl) derivatives (S.56; Brown et al., 1989a).
2′-O-Mthp derivatives (S.54) are usually ob-
tained as pure crystalline solids in satisfactory
to good yields (Reese et al., 1970).
The half times for the hydrolysis of 2′-O-
Mthp-uridine and 2′-O-Mthp-adenosine (S.54,
B = uracil-1-yl and adenosine-9-yl, respec-
tively) in 0.01 mol dm−3 hydrochloric acid at
22°C were found to be 18.7 and 34 min, respec-
tively (Norman et al., 1984). It is interesting to
note that the removal of the Mthp protecting
group from 2′-O-Mthp-uridylyl-(3′→5′)-urid-
ine (S.57a) and 2′-O-Mthp-adenylyl-(3′→5′)-
adenosine (S.57b; Fig. 2.2.16) under the same
conditions was found to proceed at signifi-
cantly faster rates (t1/2 = 6.1 and 19.9 min,
respectively; Norman et al., 1984). The rate of
removal of the Thp protecting group from 2′-
O-Thp-UpU (S.49) is also faster than from
2′-O-Thp-uridine (S.47a; Griffin et al., 1968).
O
O
Ura
PO
O
HO
OThp
O
49
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O
Ura
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O
HO
OH
O
50
O
HO
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O
HO
Ura
OH
H3O
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O
Ura
PO
O
HO
O
51
O
HO
Ura
OH
HO
Ura = uracil-1-yl
Figure 2.2.14 Scheme showing conversion of 2′-O -Thp-UpU into unprotected uridylyl-(3′→5′)-
uridine (S.50) and the structure of its (2′→5′)-isomer (S.51).
HO BO
HO OH
O BO
O OH
53
O BO
O OH
56
(i-Pr)2Si
(i-Pr)2Si
O
52
R
R'
O
O
HO BO
HO O
54
O
OMe
(Mthp)
O
OMe
55
iii
i, ii
i, iv
Figure 2.2.15 Scheme showing preparation of 2′-O -Mthp ribonucleoside derivatives (S.54) via
3′,5′-di-O-acyl-ribonucleosides (S.53) or 3′,5′-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl) deriva-
tives (S.56). Reagents: (i) 4-methoxy-5,6-dihydro-2H-pyran (S.55), toluene-4-sulfonic acid (TsOH),
dioxane; (ii) NH3, MeOH; (iii) (i-Pr)2Si(Cl)OSi(Cl)(i-Pr)2, imidazole, MeCN; (iv) Et4NF, MeCN.
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The fact that the presence of a vicinal phos-
phodiester internucleotide linkage appears to
facilitate the acid-catalyzed unblocking of a
2′-O-Mthp- or 2′-O-Thp-protected hydroxy
function is clearly advantageous if migration
and cleavage of the internucleotide linkages
(Fig. 2.2.2B) in the final unblocking step of
oligoribonucleotide synthesis are to be kept to
a minimum. As well as being achiral, Mthp has
an additional advantage over Thp in that it is
more labile to acidic hydrolysis.
The Mthp and Thp protecting groups have
been used in both solution- and solid-phase
synthesis of RNA sequences. The Mthp group
was introduced particularly for solution-phase
synthesis, and it has been used successfully in
the preparation of the 3′-terminal decamer,
nonadecamer, and heptatriacontamer (37-mer)
sequences (r[UpCpGpUpCpCpApCpCpA],
r[ApUpUpCpCpGpGpApCpUpCpGpUpCpCp-
ApCpCpA], and r[GpGpApGpApGpGpUp-
CpUpCpCp GpGpTpψpCpGpApUpUpCpCp-
GpGpApCpUpCpGpUpCpCpApCpCpA], re-
spectively) of yeast alanine transfer RNA
(tRNAAla; Jones et al., 1980, 1983; Brown et
al., 1989a,b). This work has already been re-
viewed (Reese, 1989).
The tetrahydrofuran-2-yl (Thf) and 1,5-
dimethoxycarbonyl-3-methoxypentan-3-yl
(Mdmp) groups
The above approach to the solution-phase
synthesis of RNA sequences was successful
largely because treatment with acid was com-
pletely avoided until the final unblocking step.
However, other workers (Ohtsuka et al., 1984)
reported a solution-phase block synthesis of a
tritriacontamer (33-mer) sequence of E. coli
tRNA2Gly using tetrahydrofuran-2-yl (Thf;
S.59; Fig. 2.2.17) and DMTr groups for the
protection of the 2′- and 5′-hydroxy functions,
respectively. The 5′-terminal DMTr protecting
groups were removed by treatment with zinc
bromide in dry dichloromethane/isopropanol
solution rather than with a protic acid. Although
Thf is more labile than Thp (and probably also
Mthp) to acid-catalyzed hydrolysis (Kruse et
al., 1979), the latter combination of protecting
groups was apparently effective.
There are a number of reports in the litera-
ture relating to solid-phase RNA synthesis in
which the 2′-hydroxy functions are protected
by Thp, Mthp, or Thf groups and the 5′-hydroxy
functions are also protected with acid-labile
groups (Tanaka et al., 1986; Kierzek et al.,
1986; Iwai et al., 1987; Tanimura et al., 1989;
Tanimura and Imada, 1990). Such acid-labile
groups include DMTr (S.10b), 9-phenylxan-
then-9-yl (S.11) ,  and 9-(4-methoxy-
phenyl)xanthen-9-yl (S.60; Fig. 2.2.17; UNIT
2.3). Although some sequences appear to have
been prepared successfully in this way, other
reports suggest that this is an unsound strategy,
particularly for the synthesis of comparatively
high-molecular-weight RNA sequences (Reese
and Skone, 1985; Christodoulou et al., 1986;
Kierzek, 1994). Even when precautions are
taken to maintain stringently anhydrous condi-
tions, the repeated exposure of the growing
protected oligoribonucleotide to di- or tri-chlo-
roacetic acid in order to remove the 5′-protect-
ing group in each synthetic cycle is likely to
lead to some loss of such relatively labile 2′-
O
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a, B = uracil-1-yl
b, B = adenin-9-yl
Figure 2.2.16 Scheme illustrating the removal of the Mthp protecting group.
O
59
O
60
MeO
Figure 2.2.17 Tetrahydrofuran-2-yl (S.59)
and 9-(4-methoxyphenyl)xanthen-9-yl (S.60)
protecting groups.
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protecting groups, resulting both in cleavage
and migration of internucleotide linkages
(Pathak and Chattopadhyaya, 1985; Reese and
Skone, 1985; Kierzek, 1994). If Thp, Mthp, or
Thf groups are to be used to protect the 2′-hy-
droxy functions, it would appear to be a better
strategy in solid-phase synthesis to protect the
5′-terminal hydroxy function with a group that
is readily removable under virtually neutral or
mildly basic conditions. Thus, following van
Boom’s use of the levulinyl group (as in S.61;
Fig. 2.2.18) for the protection of the 5′-hydroxy
functions in solution-phase synthesis (den Har-
tog et al., 1981), other workers (Iwai and Oht-
suka, 1988) successfully used Lev in conjunc-
tion with Thf in solid-phase oligoribonu-
cleotide synthesis. The Lev group was removed
(Fig. 2.2.18) in the usual way (den Hartog et
al., 1981) by treatment with hydrazine hydrate
in pyridine/acetic acid solution. A number of
RNA sequences, including a heneicosamer (21-
mer), were prepared in this way. In another
study (Lehmann et al., 1989), the Fmoc group
(S.12) was used to protect the 5′-hydroxy func-
tions in solid-phase oligoribonucleotide syn-
thesis. These workers protected the 2′-hydroxy
functions with Mthp groups (as in S.63) and
removed the Fmoc group with 1,8- diazabicy-
clo[5.4.0]undec-7-ene (DBU) in acetonitrile
solution (Fig. 2.2.18). As the authors (Lehmann
et al., 1989) pointed out, it is very likely that
some concomitant loss of the 2-cyanoethyl pro-
tecting groups from the partially protected oli-
goribonucleotides (S.63) occurs during DBU
treatment. A nonadecamer and an icosamer
(20-mer) RNA sequence were prepared suc-
cessfully in this way.
Although the above approach using either
2′-O-Thf and 5′-O-Lev protection or 2′-O-
Mthp and 5′-O-Fmoc protection (Fig. 2.2.18)
was successful, it is much more convenient to
use the acid-labile DMTr (S.10b) or Px (S.11)
groups to protect the 5′-hydroxy functions in
solid-phase RNA synthesis. The latter modified
trityl groups can be rapidly and quantitatively
removed under anhydrous conditions and the
released carbocations can easily be assayed
spectrophotometrically (Brown and Brown,
1991). For this reason, attempts have been
made to develop somewhat more sophisticated
acetal protecting groups that are stable under
normal “detritylation” conditions and are also
sufficiently labile to acidic hydrolysis in the
final unblocking step for cleavage and migra-
tion of the internucleotide linkages (Fig.
2.2.2B) to be avoided. Chattopadhyaya and
co-workers (Sandström et al., 1985) showed
that the 1,5-dimethoxycarbonyl-3-methoxypen-
tan-3-yl (Mdmp) group (as in S.65; Fig. 2.2.19),
derived from dimethyl 4-ketopimelate, was
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Figure 2.2.18 Scheme showing removal of levulinyl (top) and Fmoc (bottom) protecting groups.
Reagents: (i) N2H4⋅H2O, C5H5N, AcOH; (ii) 0.1 M 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU),
MeCN.
Current Protocols in Nucleic Acid Chemistry
2.2.12
Protection of 2′-
Hydroxy
Functions of
Ribonucleosides 
converted under the standard ammonolytic un-
blocking conditions used in solid-phase synthe-
sis into the corresponding bis-amide (S.66),
which was seventeen times more labile to acidic
hydrolysis than the bis-ester (S.65). However,
the Mdmp protecting group itself is unlikely to
find application in solid-phase synthesis of oli-
goribonucleotides as it undergoes hydrolysis in
4:1 (v/v) acetic acid/water solution even more
rapidly than the Mthp group.
The 1-Aryl-4-methoxypiperidin-4-yl (Ctmp
and Fpmp) groups
Acetal hydrolysis is a second-order reac-
tion; its rate, which is proportional to the con-
centrations both of substrate and hydrogen
ions, is very sensitive to inductive effects
(Kreevoy and Taft, 1955). Thus 5′-O-(4-
methoxytetrahydrothiopyran-4-yl)-thymidine
(S.67b; Fig. 2.2.19) was found to be ∼5 times
more labile to acidic hydrolysis than the corre-
sponding Mthp derivative (S.67a) and was es-
timated to be >2000 times more labile than the
corresponding sulfone (S.67c; van Boom et al.,
1972). It seemed possible that, if the aryl sub-
stituent Ar were selected carefully, a 1-aryl-4-
methoxypiperidin-4-yl protecting group (as in
S.68) could be identified that would be almost
fully protonated (as in S.69) under detritylation
conditions (i.e., in dichloromethane contain-
ing, for instance, 2% to 3% trichloroacetic
acid), but would be virtually unprotonated (as
in S.68) under the milder conditions of acidic
hydrolysis obtaining in the final unblocking
step of oligoribonucleotide synthesis. Al-
though it would, of course, depend on the aryl
substituent, it seemed possible that the rate of
hydrolysis of the unprotonated and protonated
piperidinyl species might correspond approxi-
mately to those of the Mthp (S.67a) and sulfone
(S.67c) derivatives, respectively. In the overall
rate expression for the hydrolysis of a 1-aryl-
4-methoxypiperidin-4-yl derivative, it is rea-
sonable to assume that the component relating
to the hydrolysis of the conjugate acid S.69 is
likely to be negligible in comparison with that
relating to the unprotonated S.68 and that, as a
first approximation, it can be ignored. If this is
the case, the observed rate of hydrolysis of the
1-aryl-4-methoxypiperidin-4-yl acetal system
should be pH independent. For example, if the
pH of the hydrolytic medium is lowered by one
unit, the concentration of the unprotonated
acetal S.68 will decrease by an order of mag-
nitude, and at the same time the rate of hydroly-
sis of the remaining unprotonated acetal will
increase by an order of magnitude.
Despite the very limited synthetic method-
ology available at the outset, it was possible to
prepare 2′-O-[1-(2-chloro-4-methylphenyl)-4-
methoxypiperidin-4-yl] (Ctmp) ribonu-
cleoside derivatives (S.71a; Fig. 2.2.20A) and
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Figure 2.2.19 Acetal protecting groups labile to acidic hydrolysis.
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show that the Ctmp protecting group had the
desired properties (Reese et al., 1986). Thus it
can be seen from Figure 2.2.21 that the rate of
hydrolysis of 2′-O-Ctmp-uridine (S.71a, B =
uracil-1-yl) at 30°C is only 1.75 times faster at
pH 0.5 than it is at pH 2.5. At 25°C, 2′-O-Ctmp-
uridine is ∼40 times more stable than 2′-O-
Mthp-uridine (S.54, B = uracil-1-yl) at pH 1.0
(Reese et al., 1986), but it is nearly 1.6 times
more labile than 2′-O-Mthp-uridine at pH 3.0.
The first general criterion that all protecting
groups should meet (see above) is that they
should be easy to introduce, and an important
part of this criterion is that the reagent required
should be readily accessible. The Ctmp and
related piperidine-derived protecting groups
are easy to introduce, but until recently the
preparation of the enol ether reagents (such
as S.70) involved a number of steps. How-
ever, these 1-aryl-4-methoxy-1,2,5,6-tetrahy-
dropyridine derivatives can now be readily pre-
pared (Fig. 2.2.20B) in two steps and in good
overall yields (Faja et al., 1997) from 1,5-di-
chloropentan-3-one (S.73; Owen and Reese,
1970) and the appropriate primary aromatic
amine (S.74). The procedure for the preparation
of 2′-O-(1-aryl-4-methoxypiperidin-4-yl) ri-
bonucleoside derivatives (such as S.71; Fig.
O BO
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a, R1 = Cl, R2 = Me
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Figure 2.2.20 (A) Scheme showing preparation of Ctmp (S.71a) and Fpmp (S.71a) ribonu-
cleoside derivatives. (B) Preparation of the 1-aryl-4-methoxy-1,2,5,6-tetrahydropyridines (S.70)
required in (A). Reagents (i) S.70, CF3CO2H, CH2Cl2; (ii) Et4NF, MeCN; (iii) ethylene, AlCl3, CH2Cl2;
(iv) toluene-4-sulfonic acid monohydrate (TsOH⋅H2O), MeOH, and reflux followed by (MeO)3CH;
(v) (i-Pr)2NEt, Et2O→BF3, CH2Cl2, 0°C.
Figure 2.2.21 Dependence of half times (t1/2)
on pH for hydrolysis of 2′-O -Ctmp-uridine
(S.71a)  and 2′-O -Fpmp-uridine (S.71b)  at
30°C.
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2.2.20A; Rao et al., 1987, 1993) is closely
similar to that used in the preparation of the
corresponding 2′-O-Mthp derivatives (S.54;
Fig. 2.2.15), except that a much smaller excess
of the enol ether reagent S.70 is needed.
The 2′-O-Ctmp protecting group was used
in conjunction with the 5′-O-Px protecting
group (Rao et al., 1987) or the 5′-O-DMTr
protecting group (Sakatsume et al., 1989) in
the solid-phase synthesis of oligoribonu-
cleotides. Phosphoramidite building blocks
(S.76; Fig. 2.2.22) were successfully used in
the preparation of the 3′-terminal nonadecamer
sequence r[ApUpUpCpCpGpGpApCpUp
CpGpUpCpCpApCpCpA] of yeast tRNAAla
(Rao et al., 1987), and H-phosphonate building
blocks (S.77) were used successfully in the
preparation of the octadecamer sequence,
r[ApGpUpApUpApApGpApGpGpApCpApUp
ApUpG] (Sakatsume et al., 1989). However, the
required enol ether reagent (S.70) was difficult
to prepare by the original procedure (Reese et
al., 1986), and its preparation by the improved
protocol (Fig. 2.2.20B; Faja et al., 1997) in-
volves either the use of an expensive aromatic
amine (S.74a) or an additional chlorination
step.
It was later found that several other 1-aryl-
4-methoxypiperidin-4-yl groups were also
suitable for the protection of the 2′-hydroxy
functions in solid-phase oligoribonucleotide
synthesis .  Among these is the 1-(2-
fluorophenyl)-4-methoxypiperidin-4-yl
(Fpmp) protecting group (as in S.71b; Reese
and Thompson, 1988). The Fpmp protecting
group has two distinct advantages over the
Ctmp group. First, the enol ether reagent S.70b,
which is a low-melting solid, is readily pre-
pared (Faja et al., 1997) from 2-fluoroaniline
(S.74b), which is an inexpensive starting ma-
terial. Secondly, the Fpmp group is somewhat
more stable than the Ctmp group to acidic
hydrolysis in the pH range of 0.5 to 1.0 (∼1.4
times at 30°C; Fig. 2.2.21), and therefore the
risk of concomitant 2′-unblocking in the de-
tritylation steps is even smaller. However, re-
moval of the 2′-O-Fpmp protecting group oc-
curs more slowly than removal of the 2′-O-
Ctmp group in the final unblocking step of
oligoribonucleotide synthesis, and this can be
disadvantageous (see below). It can be seen
from Figure 2.2.21 that at 30°C the rate of
hydrolysis of 2′-O-Fpmp-uridine (S.71b; B =
uracil-1-yl) is only about twice as fast at pH 0.5
as at pH 2.5.
The 2′-O-Fpmp protecting group has been
widely used in solid-phase oligoribonucleotide
synthesis (Beijer et al., 1990; Rao et al., 1993;
Capaldi and Reese, 1994; Pieles et al., 1994;
Sproat et al., 1994; Rao and Macfarlane,
1995; McGregor et al., 1996). The 5′-O-Px-
2′-O-Fpmp phosphoramidite building blocks
S.78 (Fig. 2.2.23) were used successfully in
the synthesis of r[UpCpGpUpCpCpApCpCpA],
r[ApUpUpCpCpGpGpApUpCpGpUpCpCp
ApCpCpA], and r[GpGpApGpApGpGpUp
CpUpCp CpGpGpUpUpCpGpApUpUpCpCpGp
GpApCpUpCpGpUpCpCpApCpCpA], the
3′-decamer, nonadecamer, and heptatriacon-
tamer (37-mer) sequences, respectively, of un-
modified yeast tRNAAla (Rao et al., 1993).
Sproat and co-workers (Pieles et al., 1994)
carried out the solid-phase synthesis of some
modified oligoribonucleotides containing
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76
PONC
N(i-Pr)2 Et3NH
Figure 2.2.22 Ctmp-protected phosphoramidite (S.76) and H-phosphonate (S.77).
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Figure 2.2.23 5′-O -Px-2′-O -Fpmp phosphoramidite (S.78) ,  5′-O -DMTr-2′-O -Fpmp phos-
phoramidite (S.79), and 5′-O -DMTr-2′-O -methyl-ribonucleoside phosphoramidite (S.80).
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pseudouridine, 2′-O-methylpseudouridine,
and some other 2′-O-methyl-ribonucleoside
residues starting from the appropriate 5′-O-
DMTr-2′-O-Fpmp and 5′-O-DMTr-2′-O-
methyl-ribonucleoside phosphoramidites (S.79
and S.80, respectively). In all of the early work
(Rao et al., 1993), the 2′-O-Fpmp and 5′-termi-
nal Px (or DMTr) protecting groups were re-
moved by treatment with 0.01 mol dm−3 hydro-
chloric acid (pH ∼2) at room temperature. How-
ever, it soon became clear that the susceptibility
of the internucleotide linkages of oligoribonu-
cleotides to acid-catalyzed cleavage and migra-
tion was sequence dependent, and that certain
sequences were unstable at pH 2 and room
temperature (Capaldi and Reese, 1994). Thus,
despite the relative stability of uridylyl-
(3′→5′)-uridine (S.50; Griffin et al., 1968) at
pH 2 and room temperature, r[(Up)9U] and
r[(Up)19U] both underwent virtually complete
degradation in the course of the removal of the
2′-O-Fpmp protecting groups under the same
conditions (Capaldi and Reese, 1994). How-
ever, when unblocking was carried out at room
temperature above pH 3.0, virtually no internu-
cleotide cleavage or migration could be de-
tected (see Conclusions). Other workers sub-
sequently reported that no cleavage or migra-
tion of the internucleotide linkages could be
detected after r[(Up)20U] had been allowed to
stand at pH 3.25 in 0.5 M sodium acetate buffer
solution at room temperature for 96 hr (Rao and
Macfarlane, 1995), which is very much more
than the time required to remove the 2′-O-Fpmp
protecting groups. These workers went on to
recommend that 2′-O-Fpmp protecting groups
be removed at pH 3.25 and 30°C in 0.5 M
sodium acetate buffer solution. They success-
fully unblocked RNA sequences containing up
to 50 nucleoside residues under these condi-
tions, and obtained oligoribonucleotides that
were active as ribozymes and ribozyme sub-
strates.
Other acetal groups
Three other interesting and potentially use-
ful acetal groups have recently been suggested
for the protection of the 2′-hydroxy functions
in solid-phase oligoribonucleotide synthesis.
Like the 2-nitrobenzyl group (as in S.34, see
above), the (2-nitrobenzyloxy)methyl group
(as in S.81a; Schwartz et al., 1992; Fig. 2.2.24)
is removable photochemically; however, possi-
bly for steric reasons, its use leads to faster and
more efficient coupling reactions. The (2-ni-
trobenzyloxy)methyl protecting group has
been used successfully in the solid-phase syn-
thesis of a number of RNA sequences including
a dodecamer, a hexadecamer, and a tritriacon-
tamer (33-mer) sequence that are all compo-
nents of ribozyme structures. The related (4-ni-
trobenzyloxy)methyl protecting group (as in
S.81b; Gough et al., 1996), which has also been
used successfully in solid-phase oligoribonu-
cleotide synthesis, is removable by treatment
with tetra-n-butylammonium fluoride in THF
solution. Finally the (2,6-dimethoxycar-
bonyl)phenoxymethyl protecting group (as in
S.82a; Rastogi and Usher, 1995), which has
been used in the solid-phase synthesis of two
dinucleoside phosphates, is extremely (over
100 times more than the Fpmp group) stable
under standard detritylation conditions. After
the assembly of the desired RNA sequences,
the two methoxycarbonyl groups are saponi-
fied by treatment with aqueous sodium hydrox-
ide, which also releases the product from the
solid support and removes base-labile protect-
ing groups. The resulting (2,6-dicarboxy)phe-
noxymethyl acetal system (as in S.82b) is esti-
mated to be >1300 times more labile to acidic
hydrolysis at pH 3.0 than the original (2,6-di-
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81a, R1 = NO2, R2 = H
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Figure 2.2.24 Additional acetal protecting groups: (2-nitrobenzyloxy)methyl (S.81a), (4-nitroben-
zyloxy)methyl (S.81b), (2,6-dimethoxycarbonyl)phenoxymethyl (S.82a), and (2,6-dicarboxy)phen-
oxymethyl (S.82b).
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methoxycarbonyl)phenoxymethyl acetal sys-
tem; however, it is still ∼2.3 times more stable
at pH 3.0 than the Fpmp protecting group.
Ester Protecting Groups
It has been known for many years that iso-
meric 2′- and 3′-O-acyl-ribonucleoside deriva-
tives (S.83 and S.84, respectively; Fig. 2.2.25)
interconvert under mildly basic conditions, and
that the equilibrium mixture eventually ob-
tained is generally somewhat richer in the 3′-
isomer (Reese and Trentham, 1965). Unlike
corresponding mixtures of 2′- and 3′-O-
TBDMS derivatives (e.g., S.39 and S.40; Fig.
2.2.9), it is usually very difficult or even impos-
sible to separate isomeric mixtures of 2′- and
3′-esters (S.83 and S.84) by standard chroma-
tographic methods. Furthermore, acyl migra-
tion can occur during chromatography. For
these reasons, 2′-O-acyl protecting groups have
only very rarely been used in oligoribonu-
cleotide synthesis. However, in an early study
(Fromageot et al., 1968), N2,O2′,O5′-tribenzoyl-
guanosine (S.85a; Fig. 2.2.26) and N4,O2′,O5′-
triacetylcytidine (S.85b), two pure crystalline
compounds, were both successfully coupled
with 2′,3′-di-O-acetyluridine 5′-phosphate
(S.86) by the now obsolete phosphodiester ap-
proach in solution to give, after deprotection,
guanylyl-(3′→5′)-uridine (S.87; B = guanin-9-
yl) and cytidylyl-(3′→5′)-uridine (S.87; B =
cytosin-1-yl), respectively. Both of the latter
dinucleoside phosphates were apparently free
from their (2′→5′)-isomers.
Two later studies relating to the use of 2′-O-
acyl protecting groups in solid-phase oligori-
bonucleotide synthesis are also of interest. In
one study (Kempe et al., 1982), oligoribonu-
cleotides and chimeric RNA:DNA sequences
were prepared from 2′-O-benzoyl-protected
phosphoramidites (S.88; Fig. 2.2.27). How-
ever, as these phosphoramidites (S.88) were
contaminated with 1% to 3% of the isomeric
2′-phosphoramidites, the integrity of the inter-
nucleotide linkages in the target RNA se-
quences was to some extent compromised.
The other study (Rozners et al., 1992) de-
scribed the solid-phase synthesis of oligori-
bonucleotides from 2′-O-(2-chlorobenzoyl)-
3′-H-phosphonate building blocks (S.89). This
is a more promising approach for two reasons.
First, it was possible to separate the isomeric
O
HO
BR2O
O
O
O
BR2O
OHO O
R1R1
83 84
Figure 2.2.25 Scheme showing interconversion of isomeric 2′- and 3′-O -acyl-ribonucleoside
derivatives.
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b, B = 4-N-acetylcytosin-1-yl, R = Me
Figure 2.2.26 Scheme showing preparation of guanylyl-(3′→5′)-uridine and cytidylyl-(3′→5′)-
uridine using a 2′-O -acyl protecting group. Reagents: (i) mesitylene-2-sulfonyl chloride, C5H5N; (ii)
MeNH2, EtOH, or NH3, MeOH.
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2′- and 3′-H-phosphonates (S.90 and S.89, re-
spectively) by chromatography on silica gel,
and thereby obtain isomerically pure building
blocks (S.89). Secondly, after the desired RNA
sequences had been assembled, the 2′-protect-
ing groups could be removed by ammonolysis
under conditions that were mild enough to
avoid cleavage of the internucleotide linkages.
A number of RNA sequences of moderate
length were prepared successfully by this ap-
proach.
CONCLUSIONS
At present, the TBDMS group (as in S.37;
Fig. 2.2.28) is the most widely used protecting
group for 2′-hydroxy functions in solid-phase
oligoribonucleotide synthesis. The Fpmp (as in
S.71b; Fig. 2.2.28) group is also widely used.
Both 2′-O-TBDMS- and 2′-O-Fpmp-protected
phosphoramidites (S.41 and S.79, respectively)
are commercially available. So far, there is no
report in the literature that constitutes a thor-
ough and definitive comparison of these two
protecting groups. However, it is worthwhile
discussing how they meet the necessary criteria
for protecting groups in oligoribonucleotide
synthesis, and also whether improvements
could be made by modifying them.
With regard to the introduction of these two
protecting groups, the reagents required,
namely tert-butylchlorodimethylsilane and 1-
(2-fluorophenyl)-4-methoxy-1,2,5,6-tetrahy-
dropyridine (S.70b; Fig. 2.2.28) are both readily
available. However, as far as the introduction of
these protecting groups is concerned, the Fpmp
group has the edge over the TBDMS group
inasmuch as it can be introduced regiospecifi-
cally (Fig. 2.2.20A) and cannot then migrate. As
indicated above, great care has to be exercised
in the preparation of TBDMS-protected build-
ing blocks (S.41) in order to avoid contamina-
tion with the isomeric 2′-phosphoramidites
(S.42; Fig. 2.2.10), the presence of which will
inevitably lead to (2′→5′)-internucleotide link-
ages in the final product.
In solid-phase synthesis involving phos-
phoramidite building blocks, it seems clear that
coupling rates and efficiencies are generally
lower when ribonucleoside rather than 2′-de-
oxyribonucleoside building blocks are used
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Figure 2.2.28 Structures relating to a discussion of the relative merits of the TBDMS and Fpmp
protecting groups.
O
H
B
P O
O
DMTrO
O
O
O
O
BDMTrO
OBz
88
PMeO
NMe2
O
Cl
89
O
O
BDMTrO
O
90
O
P
H
Cl
Figure 2.2.27 2′-O -Benzoyl-protected 3′-phosphoramidite (S.88), 2′-O -(2-chlorobenzoyl)-pro-
tected 3′-H-phosphonate (S.89), and the isomeric 2′-H-phosphonate (S.90).
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(Hayakawa et al., 1996). It is not yet clear
whether TBDMS-protected or Fpmp-protected
phosphoramidites (S.41 or S.79; Fig. 2.2.28) are
the more hindered. Although TBDMS ethers
(Kawahara et al., 1996) and Fpmp acetals are
both susceptible to acid-catalyzed hydrolysis,
the available evidence suggests that both groups
remain intact under the anhydrous acidic con-
ditions used during the detritylation steps. The
Fpmp group has advantages over the TBDMS
protecting group in the ammonolytic unblock-
ing step at the end of the synthesis. First, in the
Fpmp approach, adenine, cytosine, and guanine
base residues are protected with relatively stable
acyl groups (as in S.16, R = Me3C, S.18, R =
Ph, and S.19, R = PhCH2, respectively; Fig.
2.2.4; Rao et al., 1993). However, it is advisable
to use much more labile acyl protecting groups
in the TBDMS approach (Chaix et al., 1989).
More importantly, as the Fpmp protecting group
is completely stable under the ammonolytic
conditions, “Fpmp-on” RNA sequences (S.91;
Fig. 2.2.29) are obtained (Rao et al., 1993). Such
“Fpmp-on” oligoribonucleotides are stable to
endonucleases and base, and may be conven-
iently purified and stored. On treatment with
aqueous acid under very mild conditions (see
below), they are readily converted into unpro-
tected RNA sequences (S.92). “TBDMS-on”
RNA sequences do not appear to have been
purified and isolated in this way.
The one clear advantage that the TBDMS
approach has over the Fpmp approach is that
removal of the TBDMS protecting group in the
final unblocking step does not normally involve
acidic hydrolysis, and therefore cannot lead to
migration of the internucleotide linkages. How-
ever, such migration in the Fpmp approach can
be virtually eliminated by carefully controlling
the unblocking conditions. Hecht and co-work-
ers (Morgan et al., 1995) reported that when
S.91 (B = uracil-1-yl, n = 21; Fig.2.2.29) was
unblocked in 0.5 mol dm−3 sodium acetate
buffer, pH 3.25, at 25°C for 20 hr, analysis of
the resulting r[(Up)20U] (S.92; B = uracil-1-yl,
n = 21) revealed that an average of 0.40%
migration per internucleotide linkage had oc-
curred. However, Reese et al. (unpub. observ.)
have found that under somewhat milder un-
blocking conditions (0.5 mol dm−3 sodium ace-
tate buffer, pH 4.0, at 35°C), unblocking of S.91
(B = uracil-1-yl, n = 20) was complete after 9
hr and no migration of internucleotide linkages
could be detected in the resulting r[(Up)19U]
(S.92; B = uracil-1-yl, n = 20). As has been
suggested before (Capaldi and Reese, 1994), it
cannot be concluded from the results obtained
by Strömberg and co-workers (Rozners et al.,
1994) in connection with the use of 2′-O-Ctmp-
5′-O-DMTr-uridine 3′-H-phosphonate (S.77;
B = uracil-1-yl; Fig. 2.2.22) and the corre-
sponding Fpmp-protected H-phosphonate
building block in the synthesis of r[(Up)11U]
and r[(Up)11A] that Ctmp and Fpmp are unsuit-
able protecting groups for the 2′-hydroxy func-
tions in the H-phosphonate approach to the
solid-phase RNA synthesis. A much more
likely explanation for Strömberg’s observa-
tions is that r[(Up)11U] and r[(Up)11A], like
r[(Up)9U] and r[(Up)19U] (Capaldi and Reese
1994), are particularly labile at pH 2.0 and room
temperature.
Although it is clear that the solid-phase
synthesis of relatively high-molecular-weight
RNA sequences using TBDMS, Fpmp, or other
groups to protect the 2′-hydroxy functions is
now a feasible proposition, it is likely that even
better protecting groups will be identified in the
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Figure 2.2.29 Unblocking of 2′-O -Fpmp-protected oligoribonucleotides under mild conditions of
acidic hydrolysis.
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future. The next generation of 2′-protecting
groups could include modifications of
TBDMS, Fpmp, and some of the other groups
described above, and it could also include com-
pletely different groups. Any alternative silyl
protecting group (S.93; Fig. 2.2.30) would need
to be bulky to be sufficiently stable, and so far
there is no evidence that any such group is likely
to have superior properties to those of the
TBDMS group itself. However, modification
of the Fpmp group could well lead to improve-
ments. A choice is already available between
the Fpmp group, which has the advantage of
being more stable at low pH (Fig. 2.2.21) during
the detritylation steps, and the Ctmp group,
which has the advantage of being more labile
at high pH during the final unblocking step. It
might well be possible, by a careful choice of
R1 and R2, to identify a 1-aryl-4-alk-
oxypiperidin-4-yl protecting group (S.94; Fig.
2.2.30) that is as stable as (or perhaps even more
stable than) the Fpmp group at low pH and as
labile as (or perhaps even more labile than) the
Ctmp group at high pH.
Most of the above discussion has been con-
cerned with the small-scale synthesis of RNA
sequences on a solid support. In the light of
recent developments in the possible use of oli-
gonucleotide analogs in chemotherapy, a de-
mand has arisen for the development of meth-
ods for large-scale synthesis. This may well
involve a shift from solid-phase to solution-
phase methodology. While this need not neces-
sarily affect the strategy of 2′-protection, the
cost of the requisite monomeric building blocks
is likely to become a matter of crucial impor-
tance. Therefore, particular emphasis will need
to be laid on the first general criterion for
protecting groups–that they should be easy to
introduce and that the reagents involved should
be readily accessible. It is not envisaged that
this will present a problem for the Fpmp and
most other related 1-aryl-4-alkoxypiperidin-4-
yl protecting groups (S.94). Apart from the
practical problems associated with the prepara-
tion of very large quantities of 2′-O-TBDMS-
5′-O-DMTr-protected 3′-phosphoramidites
(S.41) that are free from their 2′-isomers (S.42),
there is no obvious reason why the TBDMS
group should not also be used to protect 2′-hy-
droxy functions in the large-scale synthesis of
RNA sequences in solution.
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